[1] Dabbagh A, Patel MK, Dumolard L, et al. Progress toward regional measles elimination - worldwide, 2000-2016. MMWR Morb Mortal Wkly Rep, 2017; 66, 1148−53. doi:  10.15585/mmwr.mm6642a6
[2] Minta AA, Ferrari M, Antoni S, et al. Progress toward measles elimination - worldwide, 2000-2023. MMWR Morb Mortal Wkly Rep, 2024; 73, 1036−42. doi:  10.15585/mmwr.mm7345a4
[3] World Health Organization. Progress towards measles elimination - worldwide, 2000-2024. Wkly Epidemiol Rec, 2025; 100, 591−604.
[4] Guerra FM, Bolotin S, Lim G, et al. The basic reproduction number (R0) of measles: a systematic review. Lancet Infect Dis, 2017; 17, e420−8. doi:  10.1016/S1473-3099(17)30307-9
[5] Funk S, Knapp JK, Lebo E, et al. Combining serological and contact data to derive target immunity levels for achieving and maintaining measles elimination. BMC Med, 2019; 17, 180. doi:  10.1186/s12916-019-1413-7
[6] World Health Organization. Western Pacific countries at risk of measles outbreaks due to immunization and surveillance gaps. https://www.who.int/westernpacific/news/item/01-03-2024-western-pacific-countries-at-risk-of-measles-outbreaks-due-to-immunization-and-surveillance-gaps. [2025-11-11].
[7] Zibolenová J, Hudečková H, Chladná Z, et al. Quantification of waning immunity after measles vaccination—evidence from a seroprevalence study. Am J Epidemiol, 2023; 192, 1379−85. doi:  10.1093/aje/kwad065
[8] Bolotin S, Osman S, Hughes SL, et al. In elimination settings, measles antibodies wane after vaccination but not after infection: a systematic review and meta-analysis. J Infect Dis, 2022; 226, 1127−39. doi:  10.1093/infdis/jiac039
[9] Pradhan SK, Panda A, Debata I, et al. Seroprevalence of measles antibodies among migrant populations: a systematic review and meta-analysis. Cureus, 2024; 16, e74243. doi:  10.7759/cureus.74243
[10] Szinger D, Berki T, Drenjančević I, et al. Raising epidemiological awareness: assessment of measles/MMR susceptibility in highly vaccinated clusters within the Hungarian and Croatian population—a sero-surveillance analysis. Vaccines, 2024; 12, 486. doi:  10.3390/vaccines12050486
[11] World Health Organization Regional Office for Europe. Thirteenth meeting of the European Regional Verification Commission for Measles and Rubella Elimination: 10-12 September 2024, Copenhagen, Denmark. Copenhagen: WHO Regional Office for Europe, 2025.
[12] World Health Organization Regional Office for South-East Asia. Ninth meeting of the WHO South-East Asia Regional Verification Commission for Measles and Rubella Elimination: 23-25 September 2024, Kathmandu, Nepal. New Delhi: WHO Regional Office for South-East Asia, 2024.
[13] World Health Organization. 14th meeting of the European Regional Verification Commission for Measles and Rubella Elimination. https://www.who.int/europe/news-room/events/item/2025/09/15/default-calendar/14th-meeting-of-the-european-regional-verification-commission-for-measles-and-rubella-elimination-%28rvc%29. [2026-07-15].
[14] Pan American Health Organization. PAHO calls for regional action as the Americas lose measles elimination status. https://www.paho.org/en/news/10-11-2025-paho-calls-regional-action-americas-lose-measles-elimination-status. [2025-11-10].
[15] Public Health Agency of Canada. Statement from the Public Health Agency of Canada on Canada’s measles elimination status. https://www.canada.ca/en/public-health/news/2025/11/statement-from-the-public-health-agency-of-canada-on-canadas-measles-elimination-status.html. [2025-11-23].
[16] Ward A. Canada’s measles elimination status revoked. What happens now?. https://healthsci.mcmaster.ca/canadas-measles-elimination-status-revoked-what-happens-now/. [2025-11-12].
[17] GlobalData. Measles-free status of Canada revoked. Clinical Trials Arena. https://www.clinicaltrialsarena.com/analyst-comment/measles-free-status-canada-revoked/. [2025-11-17].
[18] Torracinta L, Tanner R, Vanderslott S. MMR vaccine attitude and uptake research in the United Kingdom: a critical review. Vaccines, 2021; 9, 402. doi:  10.3390/vaccines9040402
[19] Hijazi R, Gesser-Edelsburg A, Mesch GS. The common way in which the Ministry of Health conveys information to the public: a simulation among Israeli parents with different attitudes and behaviors regarding vaccination during a measles outbreak in Israel. Disaster Med Public Health Prep, 2023; 17, e451. doi:  10.1017/dmp.2023.105
[20] Park YJ, Eom HS, Kim ES, et al. Reemergence of measles in South Korea: implications for immunization and surveillance programs. Jpn J Infect Dis, 2013; 66, 6−10. doi:  10.7883/yoken.66.6
[21] Centers for Disease Control and Prevention. Measles cases and outbreaks. https://www.cdc.gov/measles/data-research/index.html. [2026-04-23].
[22] Sunagawa T, Kobayashi Y, Takashima Y, et al. Using regular high-quality serosurveys to identify and close national immunity gaps—measles and rubella elimination in Japan. Vaccines, 2024; 12, 939. doi:  10.3390/vaccines12080939
[23] World Health Organization. WHO/UNICEF estimates of national immunization coverage. https://www.who.int/news-room/questions-and-answers/item/who-unicef-estimates-of-national-immunization-coverage. [2026-07-15].
[24] Guerra FM, Crowcroft NS, Friedman L, et al. Waning of measles maternal antibody in infants in measles elimination settings – a systematic literature review. Vaccine, 2018; 36, 1248−55. doi:  10.1016/j.vaccine.2018.01.002
[25] Li ZW, Deng LL, Li JD, et al. Epidemiological characteristics of measles-mumps-rubella in China’s mainland during 2014-2021. Biomed Environ Sci, 2024; 37, 1273−84.
[26] Schenk J, Abrams S, Theeten H, et al. Immunogenicity and persistence of trivalent measles, mumps, and rubella vaccines: a systematic review and meta-analysis. Lancet Infect Dis, 2021; 21, 286−95. doi:  10.1016/S1473-3099(20)30442-4
[27] Mazidimoradi A, Salehiniya H. Decreased vaccination coverage and recurrence risk of measles due to COVID-19 pandemic. EXCLI J, 2021; 20, 1393−9.
[28] Novilla MLB, Goates MC, Redelfs AH, et al. Why parents say no to having their children vaccinated against measles: a systematic review of the social determinants of parental perceptions on MMR vaccine hesitancy. Vaccines, 2023; 11, 926. doi:  10.3390/vaccines11050926
[29] World Health Organization. Framework for verifying elimination of measles and rubella. Wkly Epidemiol Rec, 2013; 88, 89−99.
[30] Coughlin MM, Matson Z, Sowers SB, et al. Development of a measles and rubella multiplex bead serological assay for assessing population immunity. J Clin Microbiol, 2021; 59, e02716−20.
[31] Khetsuriani N, Deshevoi S, Goel A, et al. Supplementary immunization activities to achieve measles elimination: experience of the European Region. J Infect Dis, 2011; 204, S343−52. doi:  10.1093/infdis/jir074
[32] McLean HQ, Fiebelkorn AP, Temte JL, et al. Prevention of measles, rubella, congenital rubella syndrome, and mumps, 2013: summary recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep, 2013; 62, 1−34.